Keith was diagnosed with prostate cancer in 2012 and is part of a clinical study called STAMPEDE, looking at hormone therapy in combination with other treatments as a way to treat prostate cancer.
Our research on prostate cancer
Prostate cancer is the most common cancer in UK men but more than 8 in 10 (84%) of patients now survive their disease for ten years or more. We are at the heart of this progress, and treatments continue to improve.
Help us beat prostate cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives.
Clinical trial hopes to fight prostate cancer
A pioneering new delivery system
Dr Helen McCarthy is creating a specialist nanoparticle delivery system for targeted gene therapy in patients with advanced breast or prostate cancer which has spread to the bones.
New hope for advanced prostate cancer
Our researchers helped to discover abiraterone (Zytiga), which is changing the outlook for men with prostate cancer.
Our strategy to beat cancer sooner
Our vision is to bring forward the day when all cancers are cured.Our new strategy will give us the foundations we need to tackle the challenges ahead.